Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Myosotis Investments B.V.

Private Investment Firm Utrecht, Netherlands ·Founded 2024

Overview

Myosotis Investments B.V. is a privately held company established in 2024, focusing on providing financial and business support to life science enterprises, with a particular emphasis on molecular diagnostics. The firm aims to drive meaningful, lasting improvements in healthcare and quality of life by investing in innovations that enhance patient care. The company's investment strategy includes offering loans and equity investments to early-stage and growth-stage companies in the life sciences sector. Myosotis Investments B.V. has been involved in supporting companies such as Kairos Biotech Ltd and IdeVax BV, contributing to advancements in biotechnology and diagnostics. With a commitment to a healthier world, Myosotis Investments B.V. seeks to foster innovation in healthcare by partnering with organizations that share its mission-driven approach, ultimately leading to better care for patients.

Investment Focus

Innovative life science enterprises
Focus on molecular diagnostics
Early-stage and growth-stage companies

Portfolio Companies

Kairos Biotech LtdIdeVax BV

Reach Myosotis Investments B.V. directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Myosotis Investments B.V.

What sectors does Myosotis Investments B.V. invest in?

Myosotis Investments B.V. invests in Healthcare, Life Sciences, Medical Devices, Diagnostics and Biotechnology, and is based in Utrecht, Netherlands. Myosotis Investments B.V. is listed as a private investment firm in the ConnectSafely investor database.